The Bio Report

563 Episoder

1. ALS Fight Carries Muller from Patient to Biotech CEO

   Udgivet: 11.6.2015
2. Examining the State of Sleep

   Udgivet: 5.6.2015
3. TheStreet’s Adam Feuerstein Previews ASCO 2015

   Udgivet: 28.5.2015
4. Home-Brew Morphine, Dual Use Technology, and the Biologist’s Repsonsibilities

   Udgivet: 20.5.2015
5. Reinventing Tech Transfer

   Udgivet: 14.5.2015
6. Thinking Narrowly About Antibiotics

   Udgivet: 7.5.2015
7. Promise Shown in Different Approach to Alzheimer’s

   Udgivet: 30.4.2015
8. Innovative Drugs Drive Big Increase in U.S. Spending

   Udgivet: 23.4.2015
9. Ensuring Digital Health Technologies Benefit Older People

   Udgivet: 16.4.2015
10. How the Sugar Industry Influenced Research to Protect Its Interests

    Udgivet: 10.4.2015
11. Examining The White House’s Plan to Combat Drug-Resistant Bacteria

    Udgivet: 3.4.2015
12. Weighing Adverse Events to Get at a Drug’s Real Costs

    Udgivet: 26.3.2015
13. How One Company Is Reinventing Drug Development

    Udgivet: 19.3.2015
14. Why Patent Trolling Threatens Biopharma

    Udgivet: 13.3.2015
15. Shifting Venture Investment Raises Concerns

    Udgivet: 5.3.2015
16. Will Policy Triumph Over Politics in 21st Century Cures Act

    Udgivet: 26.2.2015
17. Democratizing the World of Healthcare Analytics

    Udgivet: 19.2.2015
18. Will Funding for Obama’s Precision Medicine Initiative Match Its Ambition

    Udgivet: 12.2.2015
19. Should Investors Temper Their Enthusiasm for CAR-T Therapies

    Udgivet: 5.2.2015
20. What to Do About the United States’ Declining Investment in R&D

    Udgivet: 29.1.2015